DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Reck M, von Pawel J, Zatloukal P. et al.
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
J Clin Oncol 2009;
27 (08) 1227-1234
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.